Paris, France

Richard Lo-Man

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Richard Lo-Man: Innovator in Glycoconjugate Research

Introduction

Richard Lo-Man is a prominent inventor based in Paris, France. He has made significant contributions to the field of glycoconjugate research, holding a total of 5 patents. His work focuses on the development of methods and applications that enhance immunogenic responses through carbohydrate conjugates.

Latest Patents

Among his latest patents is a method for preparing multiple antigen glycopeptide carbohydrate conjugates. This invention relates to a method for preparing carbohydrate T cell epitope conjugates of a specific formula. Another notable patent is for the enzymatic large-scale synthesis of mucin glyconjugates, which details a process for producing mucin glycoconjugates and their biological, pharmaceutical, and medical applications. This invention notably provides mucin glycoconjugates that do not require a protein carrier to induce an immune response.

Career Highlights

Richard Lo-Man has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has significantly advanced the understanding of glycoconjugates and their potential applications in immunology.

Collaborations

Throughout his career, Richard has collaborated with notable colleagues, including Claude Leclerc and Sylvie Bay. These partnerships have further enriched his research and contributions to the field.

Conclusion

Richard Lo-Man's innovative work in glycoconjugate research has led to important advancements in immunogenic applications. His patents and collaborations reflect his commitment to enhancing scientific understanding and medical applications in this vital area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…